Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing 26 - 50 of 185
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell, Carcinoma Colon Trial in Turku (bexmarilimab)

Withdrawn
  • Carcinoma, Renal Cell
  • Carcinoma Colon
  • Turku, Finland
    Turku University Hospital
May 5, 2022

Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

Recruiting
  • Carcinoma, Renal Cell
  • New York, New York
    Columbia University Medical Center
May 6, 2022

Hyper-Personalized Medicine Using Patient Derived Xenografts for

Recruiting
  • Kidney Neoplasm
  • +2 more
    • Toronto, Ontario, Canada
      Odette Cancer Centre
    Mar 24, 2022

    Carcinoma, Renal Cell, Head and Neck Tumor, Skin Tumors Trial in Villejuif (Nivolumab)

    Active, not recruiting
    • Carcinoma, Renal Cell
    • +5 more
    • Villejuif, France
      Gustave Roussy Cancer Campus
    Mar 28, 2022

    Carcinoma, Renal Cell Trial in Dallas (Fitbit Versa)

    Terminated
    • Carcinoma, Renal Cell
    • Fitbit Versa
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Feb 21, 2022

    "Retrospective Study to Identify Clinical Factors Related toHigh

    Completed
    Has Results
    • Carcinoma, Renal Cell
      • Hospitalet de Llobregat, Barcelona, Spain
      • +39 more
      Feb 15, 2022

      Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)

      Completed
      Has Results
      • Carcinoma, Renal Cell
      • Phoenix, Arizona
      • +190 more
      Jan 18, 2022

      Carcinoma, Renal Cell Trial in Hamilton (Contrast-Enhanced Ultrasound)

      Active, not recruiting
      • Carcinoma, Renal Cell
      • Contrast-Enhanced Ultrasound
      • Hamilton, Ontario, Canada
        St. Joseph's Healthcare
      Dec 14, 2021

      Carcinoma, Renal Cell Trial in China, Korea, Republic of, Taiwan (Pazopanib, Sunitinib)

      Completed
      Has Results
      • Carcinoma, Renal Cell
      • Guangzhou, Guangdong, China
      • +20 more
      Dec 6, 2021

      Carcinoma, Renal Cell Trial in France (Tivozanib, Nivolumab)

      Completed
      • Carcinoma, Renal Cell
      • Bordeaux, France
      • +3 more
      Dec 2, 2021

      Carcinoma, Renal Cell Trial in Nijmegen (drug, radiation, procedure)

      Recruiting
      • Carcinoma, Renal Cell
      • Nijmegen, Netherlands
        Radboudumc
      Sep 23, 2021

      Carcinoma, Renal Cell, Renal Malignant Tumor, Renal Cyst Trial in Salzburg (partial nephrectomy)

      Completed
      • Carcinoma, Renal Cell
      • +3 more
      • partial nephrectomy
      • Salzburg, Austria
        Uniklinikum Salzburg, Department for Urology and Andrology
      Sep 25, 2021

      Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Yokohama City (89Zr-girentuximab)

      Completed
      • Carcinoma, Renal Cell
      • Clear Cell Renal Cell Carcinoma
      • 89Zr-girentuximab
      • Yokohama City, Kanagawa, Japan
        Yokohama City University Hospital
      Aug 18, 2021

      Carcinoma, Renal Cell, Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Nivolumab/Ipilimumab)

      Active, not recruiting
      • Carcinoma, Renal Cell
      • Clear-cell Metastatic Renal Cell Carcinoma
      • Nivolumab/Ipilimumab
      • Linz, Austria
      • +34 more
      Aug 3, 2021

      Carcinoma, Renal Cell Trial in Worldwide (BIBF 1120, sunitinib)

      Completed
      Has Results
      • Carcinoma, Renal Cell
      • Pecs, Hungary
      • +14 more
      Jun 16, 2021

      Carcinoma, Renal Cell, Fumarate Hydratase Deficiency, Immunotherapy Trial in Chengdu (Sintilimab injection plus Inlyta

      Recruiting
      • Carcinoma, Renal Cell
      • +2 more
      • Sintilimab injection plus Inlyta treatment
      • Chengdu, Sichuan, China
        West China Hospital
      Jul 11, 2021

      Carcinoma, Renal Cell Trial in Worldwide (Pazopanib, Sunitinib)

      Completed
      Has Results
      • Carcinoma, Renal Cell
      • Huntsville, Alabama
      • +226 more
      Apr 19, 2021

      Carcinoma, Renal Cell Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506))

      Completed
      Has Results
      • Carcinoma, Renal Cell
      • Regorafenib (Stivarga, BAY73-4506)
      • Los Angeles, California
      • +17 more
      Jan 27, 2021

      Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology Trial in

      Completed
      • Carcinoma, Renal Cell
      • +3 more
      • Ann Arbor, Michigan
      • +8 more
      Dec 16, 2020

      Carcinoma, Renal Cell Trial in Durham (Sunitinib)

      Completed
      Has Results
      • Carcinoma, Renal Cell
      • Durham, North Carolina
        Duke Cancer Institute
      Nov 23, 2020

      Nicotinamide Metabolism-related Protein in Newly Diagnosed Renal

      Recruiting
      • Carcinoma, Renal Cell
      • Blood test
      • Shanghai, Shanghai, China
        Xinhua Hospital affiliated to Shanghai Jiaotong University Schoo
      Nov 21, 2020

      Carcinoma, Renal Cell Trial in New York (TroVax, Interleukin-2)

      Completed
      • Carcinoma, Renal Cell
      • TroVax
      • Interleukin-2
      • New York, New York
        Columbia Presbyterian Medical Center
      Oct 8, 2020

      Carcinoma, Renal Cell Trial in Houston (TroVax, IL-2)

      Completed
      • Carcinoma, Renal Cell
      • Houston, Texas
        The Methodist Hospital
      Oct 9, 2020

      Carcinoma, Renal Cell Trial in India, Russian Federation, Ukraine (Tivozanib (AV-951), Placebo comparator)

      Completed
      Has Results
      • Carcinoma, Renal Cell
      • Tivozanib (AV-951)
      • Placebo comparator
      • Vellore, Tamil Nadu, India
      • +25 more
      Aug 17, 2020

      Data and Safety in Patients Receiving Pazopanib With Advanced or

      Completed
      • Carcinoma, Renal Cell
      • Phoenix, Arizona
      • +143 more
      Jul 14, 2020